Drug transporters in chemotherapy induced peripheral neurotoxicity: current knowledge and clinical implications

Area of Science:

• Pharmacology
• Neuroscience
• Oncology

Background:

• Antineoplastic drugs can cause severe peripheral neurotoxicity, impacting cancer patients' quality of life.
• The exact mechanisms underlying chemotherapy-induced peripheral neurotoxicity are not fully understood.
• Drug transporters are increasingly implicated in the development of this neurotoxicity.

Purpose of the Study:

• To review recent advancements in understanding the role of drug transporters in chemotherapy-induced peripheral neurotoxicity.
• To explore the potential of targeting drug transporters as a therapeutic strategy for mitigating neurotoxic side effects.

Main Methods:

• Literature review of current research on drug transporters and neurotoxicity.
• Analysis of studies investigating drug transporter distribution and activity in nervous system tissues.
• Discussion of potential therapeutic targets and strategies.

Main Results:

• Evidence suggests drug transporters play a significant role in the onset of chemotherapy-induced peripheral neurotoxicity.
• Differential expression and activity of transporters may explain selective toxicity in peripheral versus central nervous system.
• Understanding transporter mechanisms is crucial for identifying new therapeutic targets.

Conclusions:

• Drug transporters are key players in chemotherapy-induced peripheral neurotoxicity.
• Targeting these transporters presents a promising avenue for developing novel treatments to manage neurotoxic side effects.
• Further research into transporter function is essential for clinical application.